Latest biopharmaceutical Stories
JUPITER, Fla., Oct. 30, 2014 /PRNewswire/ -- Dyadic International, Inc.
DALLAS and NEW YORK, Oct. 29, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
DALLAS and NEW YORK, Oct. 27, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
Company Name Officially Changes from Access Pharmaceuticals, Inc. to PlasmaTech Biopharmaceuticals, Inc. DALLAS and NEW YORK, Oct.
ROCKVILLE, Md., Oct. 23, 2014 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCBB: RGRX) ("the Company" or "RegeneRx") today reported on data presented by Dr.
FREMONT, Calif., Oct. 23, 2014 /PRNewswire/ -- Ardelyx, Inc.
With the USA accounting for 34% of the world's pharmaceuticals, certified CNPR Pharmaceutical Sales Reps are needed to promote new products coming down the pipeline.
- Interim Results from Ongoing Study Demonstrate Human Proof-of-Concept and Underscore the Value of Regulus' microRNA Platform - LA JOLLA, Calif., Oct.
NEW YORK, Oct. 22, 2014 /PRNewswire/ -- Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) specializes in developing oncology and dermatology therapies.
Expands rHuPH20 Production SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.